Rachel Winograd, PhD, is an Assistant Research Professor at the University of Missouri St. Louis (UMSL) – Missouri Institute of Mental Health (MIMH). Her clinical, research, and program development interests have revolved around alcohol and drug use, consequences, and treatment. Dr. Winograd received her PhD in Clinical Psychology from the University of Missouri-Columbia, where she conducted multiple studies conceptualizing and characterizing “drunk personality” and its clinical relevance. She completed her predoctoral internship with the VA St. Louis Healthcare System. While at the VA, her interests shifted from alcohol use to opioid addiction, treatment, and overdose prevention. Now at UMSL-MIMH, Dr. Winograd is leading the Institute’s administration and evaluation of Missouri’s State Targeted Response to the Opioid Crisis (STR) and the Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) project. She devotes the majority of her energy to clinical, programmatic, and empirical efforts to the implementation of evidence-based opioid treatment and harm reduction approaches, namely the use of buprenorphine and methadone maintenance medications and community-based naloxone distribution.

Presentation(s)

Missouri’s State Targeted Response to the Opioid Crisis and the implementation of the ‘Medication First’ Treatment Model